Disease burden and quality of life of patients with chronic urticaria in Spain. Prevalence of chronic urticaria refractory to standard therapy in routine clinical practice. UCREX study.
Researchers
-
Albert González Martin
Dermatologist
-
Anna Ravella Matthew
Dermatologist
PhD -
David Vidal Sarro
Dermatologist
PhD -
Gisela Hebe Petiti
Dermatologist
-
Joan Antoni Smandia Domínguez
Dermatologist
PhD -
Laura Peramiquel Fonollosa
Dermatologist
-
Loida Galvany Rosell
Dermatologist
-
Mª Rosa Olivella Garcés
Dermatologist
-
Maria López Nuñez
Dermatologist
-
Maria Villar Buil
Dermatologist
-
Nuria Lamas Domenech
Dermatologist
Contact the group
Form-
Torrente-Segarra V, Petiti GH, González A, Corominas H.3 1344
Active tenosynovitis of the palmar flexor tendon in psoriatic arthritis in clinical remission.
Reumatol Clin. 2016;12(4):230-2.
-
Puig S, Marcoval J, Paradelo C, Azon A, Bartralot R, Bel S, Bigata X, Boada A, Campoy A, Carrera C, Curco N, Dalmau J, Ferrándiz C, Ferreres JR, Formigon M, Gallardo F, Gonzalez A , Just M, Llistosella E, Marti RM, Nogues ME, Pedragosa R, Pujol JA, Roldán-Marín R, Sabat M, Salleras M, Smandia JA, Zaballos P, Plana E, Malvehy J. 1314
Melanoma incidence increases in the elderly of Catalonia but not in the younger population: effect of prevention or consequence of immigration?
Acta Derm Venereol. 2015;95(4):422-6.
-
Puig L, Carrascosa JM, Carretero G, de la Cueva P, Lafuente RF, Belinchón I, Sánchez-Regaña M, García-Bustínduy M, Ribera M, Alsina M, Ferrándiz C, Fonseca E, García-Patos V, Herrera E, López-Estebaranz JL, Marrón SE, Moreno JC, Notario J, Rivera R. (Vidal D) 1115
Spanish evidence-based guidelines on the treatment of psoriasis with biological agents, 2013. Part 1: on efficacy and choice of treatment..
Actas Dermosifiliogr. 2013;104(8):694-709.
-
Carretero G, Ribera M, Belinchón I, Carrascosa JM, Puig L, Ferrandiz C, Dehesa L, Vidal D, Peral F, Jorquera E, Gonzalez-Quesada A, Muñoz C, Notario J, Vanaclocha F, Moreno JC; Psoriasis Group of the AEDV. 1116
Guidelines for the use of acitretin in psoriasis.
Actas Dermosifiliogr. 2013;104(7):598-616.
-
Puig L, de la Cueva P, Linares M, Suarez J, Velasco M, Vidal D, Zulaica A, García-Calvo C. 1117
Expert report on psoriasis: Spanish dermatologists' opinions on the use of biological agents to manage moderate to severe psoriasis in adults.
Actas Dermosifiliogr. 2013;104(5):400-8.
-
Vidal D, Altés J, Smandia JA. 1118
Yellow skin discoloration induced by quinacrine in a patient with cutaneous lupus erythematosus.
Actas Dermosifiliogr. 2013;104(1):89-90.
Projects
-
Dermatologist
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Cutaneous ultrasound and color doppler as a diagnostic technique for non-melanocytic skin tumors.
-
DISTRICT ATTORNEY:
Aragonese Institute of Health Sciences
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Observational study on quality of life and ultrasound parameters of nail psoriasis after treatment with apremilast.
-
DISTRICT ATTORNEY:
Granollers Asylum Hospital Private Foundation
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Secukimumab in the treatment of plaque psoriasis in routine clinical practice: multicenter, observational, retrospective study.
-
DISTRICT ATTORNEY:
Dr. Jaime Notary Rosa
-
TYPE E:
EPA
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Search for genetic markers predictors of response to new drugs in the treatment of psoriasis.
-
DISTRICT ATTORNEY:
Dr. Esteban Daudén Tello
-
TYPE E:
EPA
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Cutaneous ultrasound and color doppler as a diagnostic technique for non-melanocytic skin tumors.
-
DISTRICT ATTORNEY:
Aragonese Institute of Health Sciences
-
TYPE E:
PINE TREE
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Observational study on quality of life and ultrasound parameters of nail psoriasis after treatment with apremilast.
-
DISTRICT ATTORNEY:
Granollers Asylum Hospital Private Foundation
-
TYPE E:
EPA
-
- Year 2017
- Sant Joan Despí Moisès Broggi Hospital
Secukimumab in the treatment of plaque psoriasis in routine clinical practice: multicenter, observational, retrospective study.
-
DISTRICT ATTORNEY:
Dr. Jaime Notary Rosa
-
TYPE E:
EPA
-
Dermatologist
Researcher
- Year 2016
- Comprehensive Care Center Dos de Maig Hospital/Hospital de Sant Joan Despí Moisès Broggi
"Network of Melanoma Centers" Data shearing platform.
-
DISTRICT ATTORNEY:
Dr. Susana Puigde Melanoma Unit of Hospital Clínic de Barcelona
-
TYPE E:
PI
-
Dermatologist
Researcher
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital
Multicenter, randomized, double-blind, placebo-controlled, 52-week study to demonstrate the efficacy, safety, and tolerability of secukinumab subcutaneous injections with 2 mL (300 mg) prefilled syringes in adult patients with moderate to severe plaque psoriasis serious
-
DISTRICT ATTORNEY:
Novartis Farmacéutica, SA
-
TYPE E:
RD2015
-
Dermatologist
Researcher
- Year 2016
- Sant Joan Despí Moisès Broggi Hospital/Dos de Maig Hospital Integral Care Center
Registration of the Catalan and Balearic Urticaria Network (XUrCB).
-
DISTRICT ATTORNEY:
Catalan and Balearic Urticaria Network (XUrCB)
-
TYPE E:
EPA
- Immune mediated skin diseases
- Skin cancer
- neurofibromatosis
- Ultrasonography
